Maria Esther Perez Trejo

Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis

Tracey G. Simon, Maria Esther Perez Trejo, Robyn L. McClelland et al. · International Journal of Cardiology · 2018 · 79 citations

Veterinary Medicine, Cardiology, Immunology +14

Perceived access and barriers to care among illicit drug users and hazardous drinkers: findings from the Seek, Test, Treat, and Retain data harmonization initiative (STTR)

Mika Matsuzaki, Vu Minh Quan, Marya Gwadz et al. · BMC Public Health · 2018 · 67 citations · Full text

Public Health, Community Health, Health Behavior +16

Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial

Kate C. Verbeeten, Maria Esther Perez Trejo, Ken Tang et al. · Pediatric Diabetes · 2020 · 28 citations · Full text

Medicine, Child Health, Pediatrics +17

Impact of Abstinence and of Reducing Illicit Drug Use Without Abstinence on Human Immunodeficiency Virus Viral Load

Robin M. Nance, Maria Esther Perez Trejo, Bridget M. Whitney et al. · Clinical Infectious Diseases · 2019 · 25 citations · Full text

Public Health, Health Behavior, Infectious Disease Control +15

Coronary artery calcium and carotid artery intima-media thickness for the prediction of stroke and benefit from statins

Kazuhiro Osawa, Maria Esther Perez Trejo, Rine Nakanishi et al. · European Journal of Preventive Cardiology · 2018 · 22 citations · Full text

Medicine, Biostatistics, Cardiology +17